SlideShare ist ein Scribd-Unternehmen logo
1 von 21
Pharmaceutical suspension
Faysal Ahmed
Id:151-29-760
A Pharmaceutical suspension is a disperse system in which internal phase is
dispersed uniformly as finely divided insoluble particles throughout the
external phase.
Suspension
The Difference Between Solution & Suspensions:
 When the 2 substances totally mix it is called a solution.
 E.g. Solute + Solvent = Solution
(sugar) + (water) = Solution
 We then say sugar is soluble in water, it has dissolved.
The particles in a suspension are insoluble
 Sometimes when we mix substances they stay in clusters. We therefore say it is
insoluble in water.
 E.g. Chalk + Water = Suspension
 Eventually the particles sink to the bottom to form sediment.
Types of pharmaceutical suspensions:
 Antacid oral suspensions
 Antibacterial oral suspension
 Dry powders for oral suspension (antibiotic)
 Analgesic oral suspension
 Anthelmentic oral suspension
 Anticonvulsant oral suspension
 Antifungal oral suspension
 Classification:
 Based on General Classes :
Oral suspension
Externally applied suspension
Parenteral suspension
 Based on Proportion of Solid Particles:
Dilute suspension (2 to10%w/v solid)
Concentrated suspension (50%w/v solid)
 Based on Electro kinetic Nature of Solid Particles:
Flocculated suspension
Deflocculated suspension
 Based on Size of Solid Particles:
Colloidal suspension (< 1 micron)
Coarse suspension (>1 micron)
Nano suspension (10 ng)
 Formulating Consideration of Suspensions:
 Wetting agents
 Particle Size
 Particle shape
 Particle- particle Interaction
 Suspending agent
 Wetting agent:
 A substance is referred to as a wetting agent if it lowers the surface tension of a liquid
and thus allows it to spread more easily.
 It is the important factor to be considered for formulation of suspension because the
more the wetable particle the more stable the suspension.
 Wetting ability depends upon the angle of contact between the particle and the solvent
which should be less than 90 C.
 e.g: Polysorbate 80 etc.
 Particle size:
 It is critical part to be considered and the particle size must be reduced within the range.
 Too large or too small particles should be avoided.
 Large particles settle down faster.
 Smaller particles may form agglomerates.
 Required particles size maintained to form stable suspension.
 Particle shape:
 Spherical shape particles form the more viscous with low rate of sedimentation
of suspension that's why it is preferable over needle shaped particles.
 Particle- Particle Interaction:
A. Zeta potential
B. Deflocculation and
C. Flocculation.
 The zeta potential is defined as "the difference in potential between the surface of
tightly bound layer."
 If the zeta potential is reduced, the attractive forces exceed the repulsive forces and the
particles come together, this phenomena is known as flocculation
B. Flocculated Suspension:
 In flocculated suspension, formed flocs i.e. loose aggregates will increase in
sedimentation rate due to increase in size of sedimenting particeles.It also depends
upon the porosity of flocs.
C. Deflocculated Suspension:
 In this, individual particles are settling, rate of sedimentation is slow, which prevents
entrapping of liquid medium which makes it difficult to redisperse by agitation. This
phenomena known as caking.
 The larger particles settle fast and smaller remain in supernatant so supernatent appears
cloudy.
 Suspending agent:
 They form film around particle and decrease the interparticle attraction.
 They also imparts viscosity to the solution.
 Examples: Sodium alginates, Methylcellulose, CMC, silicon dioxide etc.
 Reasons for the formulation of a suspension:
 when the drug is insoluble in the delivery vehicle.
 To mask the bitter taste of the drug.
 To increase drug stability.
 To achieve sustained drug release.
 Quality Control of Suspensions:
 Appearance Color, odor and taste
 Sedimentation rate and
 Zeta Potential measurement
 Sedimentation volume
 pH
 Redispersibility and Centrifugation tests
 Rheological measurement
 Stress test
 Advantages of Suspension:
 Suspension can improve chemical stability of certain drug. E.g. Procaine penicillin G
 Drug in suspension exhibits higher rate of bioavailability than other dosage forms.
 Bioavailability is in following order:
Solution > Suspension > Capsule > Compressed Tablet > Coated tablet
 Duration and onset of action can be controlled. E.g. Protamine Zinc-Insulin
suspension
 Suspension can mask the unpleasant/ bitter taste of drug. E.g. Chloramphenicol
palmitate
 Disadvantages of Suspension:
 Physical stability, sedimentation and compaction can causes problems.
 It is bulky, therefore sufficient care must be taken during handling and transport.
 It is difficult to formulate.
 Uniform and accurate dose can not be achieved unless suspension are packed in
unit dosage form .
 Pharmaceutical Application of suspension:
 Suspension is usually applicable for drug which is insoluble or poorly soluble.
E.G. Prednisolone
 Suspension to prevent degradation of drug or to improve stability of drug. E.G.
Ox tetracycline suspension
 To mask the taste of bitter of unpleasant drug. E.G. Chloramphenicol
palmitate suspension
 Suspension of drug can be formulated for topical application E.G. Calamine
lotion.

Weitere ähnliche Inhalte

Was ist angesagt? (20)

Suspensions
SuspensionsSuspensions
Suspensions
 
Emulsion
EmulsionEmulsion
Emulsion
 
Emulsion and suspensions
Emulsion and suspensionsEmulsion and suspensions
Emulsion and suspensions
 
Suspension ppt
Suspension pptSuspension ppt
Suspension ppt
 
B.pharm- semisolid dosage form
B.pharm- semisolid dosage formB.pharm- semisolid dosage form
B.pharm- semisolid dosage form
 
Emulsion-Biphasic Liquid Dosage Form
Emulsion-Biphasic Liquid Dosage FormEmulsion-Biphasic Liquid Dosage Form
Emulsion-Biphasic Liquid Dosage Form
 
Pharmaceutical suspension
Pharmaceutical suspensionPharmaceutical suspension
Pharmaceutical suspension
 
Pharmaceutics - suspension
Pharmaceutics -  suspensionPharmaceutics -  suspension
Pharmaceutics - suspension
 
suspensions
 suspensions suspensions
suspensions
 
Pharmaceutical suspensions sb
Pharmaceutical suspensions sbPharmaceutical suspensions sb
Pharmaceutical suspensions sb
 
LIQUID DOSAGE FORMS.pptx
LIQUID DOSAGE FORMS.pptxLIQUID DOSAGE FORMS.pptx
LIQUID DOSAGE FORMS.pptx
 
Stability of suspensions
Stability of suspensionsStability of suspensions
Stability of suspensions
 
Disperse systems
Disperse systemsDisperse systems
Disperse systems
 
Pharmaceutical suspension
Pharmaceutical suspension Pharmaceutical suspension
Pharmaceutical suspension
 
Dispersion system
Dispersion systemDispersion system
Dispersion system
 
Powders
PowdersPowders
Powders
 
Powders
PowdersPowders
Powders
 
suspension
suspensionsuspension
suspension
 
PHYSICAL PHARMACEUTICS II COARSE DISPERSION
PHYSICAL PHARMACEUTICS II COARSE DISPERSION PHYSICAL PHARMACEUTICS II COARSE DISPERSION
PHYSICAL PHARMACEUTICS II COARSE DISPERSION
 
Significance of tonicity adjustment
Significance of tonicity adjustmentSignificance of tonicity adjustment
Significance of tonicity adjustment
 

Ähnlich wie pharmaceutical suspension-ppt

Suspension.pdf
Suspension.pdfSuspension.pdf
Suspension.pdfOseiTony
 
Suspensions for B.pharmacy Suspensions in Pharmaceutics
Suspensions for B.pharmacy Suspensions in PharmaceuticsSuspensions for B.pharmacy Suspensions in Pharmaceutics
Suspensions for B.pharmacy Suspensions in Pharmaceuticsgamerking23012001
 
Pharmaceutical Dosage Forms-II (Lect. 4).pdf
Pharmaceutical Dosage Forms-II (Lect. 4).pdfPharmaceutical Dosage Forms-II (Lect. 4).pdf
Pharmaceutical Dosage Forms-II (Lect. 4).pdfMariamMansour32
 
Pharmaceutical Development with focus on Paediatric Formulations
Pharmaceutical Development with focus on Paediatric FormulationsPharmaceutical Development with focus on Paediatric Formulations
Pharmaceutical Development with focus on Paediatric FormulationsJohnny Aguilar Diaz, Ph.D.
 
L1-4 suspension.pdf for pharmhacists and
L1-4 suspension.pdf for pharmhacists andL1-4 suspension.pdf for pharmhacists and
L1-4 suspension.pdf for pharmhacists andGulyChwas
 
Pharmaceutical Suspension.ppt
Pharmaceutical Suspension.pptPharmaceutical Suspension.ppt
Pharmaceutical Suspension.pptRAHUL PAL
 
Pharmaceutical Suspension Dosage Form (PPT)
Pharmaceutical Suspension Dosage Form (PPT)Pharmaceutical Suspension Dosage Form (PPT)
Pharmaceutical Suspension Dosage Form (PPT)Prachi Pandey
 
suspension ppt.pptx
suspension ppt.pptxsuspension ppt.pptx
suspension ppt.pptxanamhameed4
 
Suspension, type of suspension, interracial property of suspended particles
Suspension, type of suspension, interracial property of suspended particles Suspension, type of suspension, interracial property of suspended particles
Suspension, type of suspension, interracial property of suspended particles Dheeraj Saini
 
suspension.ppt
suspension.pptsuspension.ppt
suspension.pptavya8
 
suspension of medicated syrups for industry ppt
suspension of medicated syrups for industry pptsuspension of medicated syrups for industry ppt
suspension of medicated syrups for industry pptstiflexpharmaceutica
 
bABE STUDIES
bABE STUDIESbABE STUDIES
bABE STUDIESphanigvd
 

Ähnlich wie pharmaceutical suspension-ppt (20)

Suspension.pdf
Suspension.pdfSuspension.pdf
Suspension.pdf
 
Suspensions for B.pharmacy Suspensions in Pharmaceutics
Suspensions for B.pharmacy Suspensions in PharmaceuticsSuspensions for B.pharmacy Suspensions in Pharmaceutics
Suspensions for B.pharmacy Suspensions in Pharmaceutics
 
Suspension
SuspensionSuspension
Suspension
 
Pharmaceutical Dosage Forms-II (Lect. 4).pdf
Pharmaceutical Dosage Forms-II (Lect. 4).pdfPharmaceutical Dosage Forms-II (Lect. 4).pdf
Pharmaceutical Dosage Forms-II (Lect. 4).pdf
 
Suspension.
Suspension.Suspension.
Suspension.
 
Lecture Suspension.pdf
Lecture Suspension.pdfLecture Suspension.pdf
Lecture Suspension.pdf
 
Pharmaceutical Development with focus on Paediatric Formulations
Pharmaceutical Development with focus on Paediatric FormulationsPharmaceutical Development with focus on Paediatric Formulations
Pharmaceutical Development with focus on Paediatric Formulations
 
L1-4 suspension.pdf for pharmhacists and
L1-4 suspension.pdf for pharmhacists andL1-4 suspension.pdf for pharmhacists and
L1-4 suspension.pdf for pharmhacists and
 
Pharmaceutical Suspension.ppt
Pharmaceutical Suspension.pptPharmaceutical Suspension.ppt
Pharmaceutical Suspension.ppt
 
Pharmaceutical Suspension Dosage Form (PPT)
Pharmaceutical Suspension Dosage Form (PPT)Pharmaceutical Suspension Dosage Form (PPT)
Pharmaceutical Suspension Dosage Form (PPT)
 
suspension ppt.pptx
suspension ppt.pptxsuspension ppt.pptx
suspension ppt.pptx
 
Pharmaceutical suspension
Pharmaceutical suspensionPharmaceutical suspension
Pharmaceutical suspension
 
SUSPENSIONS.ppt
SUSPENSIONS.pptSUSPENSIONS.ppt
SUSPENSIONS.ppt
 
Suspension, type of suspension, interracial property of suspended particles
Suspension, type of suspension, interracial property of suspended particles Suspension, type of suspension, interracial property of suspended particles
Suspension, type of suspension, interracial property of suspended particles
 
Suspensions
SuspensionsSuspensions
Suspensions
 
SUSPENSIONS.pdf
SUSPENSIONS.pdfSUSPENSIONS.pdf
SUSPENSIONS.pdf
 
suspension.ppt
suspension.pptsuspension.ppt
suspension.ppt
 
suspension of medicated syrups for industry ppt
suspension of medicated syrups for industry pptsuspension of medicated syrups for industry ppt
suspension of medicated syrups for industry ppt
 
SUSPENSION.ppt
SUSPENSION.pptSUSPENSION.ppt
SUSPENSION.ppt
 
bABE STUDIES
bABE STUDIESbABE STUDIES
bABE STUDIES
 

Mehr von faysalahmed35

Niosome and Liposome
Niosome and  LiposomeNiosome and  Liposome
Niosome and Liposomefaysalahmed35
 
Phytochemical screeninig and Pharmacological studies on Leaf and stem extract...
Phytochemical screeninig and Pharmacological studies on Leaf and stem extract...Phytochemical screeninig and Pharmacological studies on Leaf and stem extract...
Phytochemical screeninig and Pharmacological studies on Leaf and stem extract...faysalahmed35
 
Factor Viii Hemophilia
Factor Viii HemophiliaFactor Viii Hemophilia
Factor Viii Hemophiliafaysalahmed35
 
Model Pharmacy and its prospect in future
Model Pharmacy and its prospect in futureModel Pharmacy and its prospect in future
Model Pharmacy and its prospect in futurefaysalahmed35
 
Tablet Coating Machine
Tablet Coating MachineTablet Coating Machine
Tablet Coating Machinefaysalahmed35
 
Basic principle of IR spectroscoy
Basic principle of IR spectroscoy Basic principle of IR spectroscoy
Basic principle of IR spectroscoy faysalahmed35
 
Oral Contraceptive Pills
Oral Contraceptive Pills Oral Contraceptive Pills
Oral Contraceptive Pills faysalahmed35
 
Pharmaceutical Excipients & Formulation of a Dosage Form
Pharmaceutical Excipients & Formulation of a Dosage FormPharmaceutical Excipients & Formulation of a Dosage Form
Pharmaceutical Excipients & Formulation of a Dosage Formfaysalahmed35
 
Genetics differences affect drug metabolism
Genetics differences affect drug metabolismGenetics differences affect drug metabolism
Genetics differences affect drug metabolismfaysalahmed35
 
Sedative & Hypnotics ppt
Sedative & Hypnotics pptSedative & Hypnotics ppt
Sedative & Hypnotics pptfaysalahmed35
 
High performance liquid chromatography(HPLC)
High performance liquid chromatography(HPLC)High performance liquid chromatography(HPLC)
High performance liquid chromatography(HPLC)faysalahmed35
 
Pharmacy and therapeutic committee(PTC)
Pharmacy and therapeutic committee(PTC)Pharmacy and therapeutic committee(PTC)
Pharmacy and therapeutic committee(PTC)faysalahmed35
 

Mehr von faysalahmed35 (15)

Niosome and Liposome
Niosome and  LiposomeNiosome and  Liposome
Niosome and Liposome
 
Phytochemical screeninig and Pharmacological studies on Leaf and stem extract...
Phytochemical screeninig and Pharmacological studies on Leaf and stem extract...Phytochemical screeninig and Pharmacological studies on Leaf and stem extract...
Phytochemical screeninig and Pharmacological studies on Leaf and stem extract...
 
Albendazole Tablet
Albendazole TabletAlbendazole Tablet
Albendazole Tablet
 
Factor Viii Hemophilia
Factor Viii HemophiliaFactor Viii Hemophilia
Factor Viii Hemophilia
 
Penicillin
PenicillinPenicillin
Penicillin
 
Model Pharmacy and its prospect in future
Model Pharmacy and its prospect in futureModel Pharmacy and its prospect in future
Model Pharmacy and its prospect in future
 
Tablet Coating Machine
Tablet Coating MachineTablet Coating Machine
Tablet Coating Machine
 
Hypertension
Hypertension Hypertension
Hypertension
 
Basic principle of IR spectroscoy
Basic principle of IR spectroscoy Basic principle of IR spectroscoy
Basic principle of IR spectroscoy
 
Oral Contraceptive Pills
Oral Contraceptive Pills Oral Contraceptive Pills
Oral Contraceptive Pills
 
Pharmaceutical Excipients & Formulation of a Dosage Form
Pharmaceutical Excipients & Formulation of a Dosage FormPharmaceutical Excipients & Formulation of a Dosage Form
Pharmaceutical Excipients & Formulation of a Dosage Form
 
Genetics differences affect drug metabolism
Genetics differences affect drug metabolismGenetics differences affect drug metabolism
Genetics differences affect drug metabolism
 
Sedative & Hypnotics ppt
Sedative & Hypnotics pptSedative & Hypnotics ppt
Sedative & Hypnotics ppt
 
High performance liquid chromatography(HPLC)
High performance liquid chromatography(HPLC)High performance liquid chromatography(HPLC)
High performance liquid chromatography(HPLC)
 
Pharmacy and therapeutic committee(PTC)
Pharmacy and therapeutic committee(PTC)Pharmacy and therapeutic committee(PTC)
Pharmacy and therapeutic committee(PTC)
 

Kürzlich hochgeladen

Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Krashi Coaching
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfchloefrazer622
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphThiyagu K
 
URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppCeline George
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991RKavithamani
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104misteraugie
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docxPoojaSen20
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpinRaunakKeshri1
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationnomboosow
 

Kürzlich hochgeladen (20)

Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdf
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
URLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website AppURLs and Routing in the Odoo 17 Website App
URLs and Routing in the Odoo 17 Website App
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
Staff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSDStaff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSD
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docx
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpin
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communication
 

pharmaceutical suspension-ppt

  • 2. A Pharmaceutical suspension is a disperse system in which internal phase is dispersed uniformly as finely divided insoluble particles throughout the external phase. Suspension
  • 3. The Difference Between Solution & Suspensions:  When the 2 substances totally mix it is called a solution.  E.g. Solute + Solvent = Solution (sugar) + (water) = Solution  We then say sugar is soluble in water, it has dissolved.
  • 4. The particles in a suspension are insoluble  Sometimes when we mix substances they stay in clusters. We therefore say it is insoluble in water.  E.g. Chalk + Water = Suspension  Eventually the particles sink to the bottom to form sediment.
  • 5. Types of pharmaceutical suspensions:  Antacid oral suspensions  Antibacterial oral suspension  Dry powders for oral suspension (antibiotic)  Analgesic oral suspension  Anthelmentic oral suspension  Anticonvulsant oral suspension  Antifungal oral suspension
  • 6.  Classification:  Based on General Classes : Oral suspension Externally applied suspension Parenteral suspension  Based on Proportion of Solid Particles: Dilute suspension (2 to10%w/v solid) Concentrated suspension (50%w/v solid)
  • 7.  Based on Electro kinetic Nature of Solid Particles: Flocculated suspension Deflocculated suspension  Based on Size of Solid Particles: Colloidal suspension (< 1 micron) Coarse suspension (>1 micron) Nano suspension (10 ng)
  • 8.
  • 9.  Formulating Consideration of Suspensions:  Wetting agents  Particle Size  Particle shape  Particle- particle Interaction  Suspending agent
  • 10.  Wetting agent:  A substance is referred to as a wetting agent if it lowers the surface tension of a liquid and thus allows it to spread more easily.  It is the important factor to be considered for formulation of suspension because the more the wetable particle the more stable the suspension.  Wetting ability depends upon the angle of contact between the particle and the solvent which should be less than 90 C.  e.g: Polysorbate 80 etc.
  • 11.  Particle size:  It is critical part to be considered and the particle size must be reduced within the range.  Too large or too small particles should be avoided.  Large particles settle down faster.  Smaller particles may form agglomerates.  Required particles size maintained to form stable suspension.
  • 12.  Particle shape:  Spherical shape particles form the more viscous with low rate of sedimentation of suspension that's why it is preferable over needle shaped particles.  Particle- Particle Interaction: A. Zeta potential B. Deflocculation and C. Flocculation.
  • 13.  The zeta potential is defined as "the difference in potential between the surface of tightly bound layer."  If the zeta potential is reduced, the attractive forces exceed the repulsive forces and the particles come together, this phenomena is known as flocculation
  • 14. B. Flocculated Suspension:  In flocculated suspension, formed flocs i.e. loose aggregates will increase in sedimentation rate due to increase in size of sedimenting particeles.It also depends upon the porosity of flocs.
  • 15. C. Deflocculated Suspension:  In this, individual particles are settling, rate of sedimentation is slow, which prevents entrapping of liquid medium which makes it difficult to redisperse by agitation. This phenomena known as caking.  The larger particles settle fast and smaller remain in supernatant so supernatent appears cloudy.
  • 16.  Suspending agent:  They form film around particle and decrease the interparticle attraction.  They also imparts viscosity to the solution.  Examples: Sodium alginates, Methylcellulose, CMC, silicon dioxide etc.
  • 17.  Reasons for the formulation of a suspension:  when the drug is insoluble in the delivery vehicle.  To mask the bitter taste of the drug.  To increase drug stability.  To achieve sustained drug release.
  • 18.  Quality Control of Suspensions:  Appearance Color, odor and taste  Sedimentation rate and  Zeta Potential measurement  Sedimentation volume  pH  Redispersibility and Centrifugation tests  Rheological measurement  Stress test
  • 19.  Advantages of Suspension:  Suspension can improve chemical stability of certain drug. E.g. Procaine penicillin G  Drug in suspension exhibits higher rate of bioavailability than other dosage forms.  Bioavailability is in following order: Solution > Suspension > Capsule > Compressed Tablet > Coated tablet  Duration and onset of action can be controlled. E.g. Protamine Zinc-Insulin suspension  Suspension can mask the unpleasant/ bitter taste of drug. E.g. Chloramphenicol palmitate
  • 20.  Disadvantages of Suspension:  Physical stability, sedimentation and compaction can causes problems.  It is bulky, therefore sufficient care must be taken during handling and transport.  It is difficult to formulate.  Uniform and accurate dose can not be achieved unless suspension are packed in unit dosage form .
  • 21.  Pharmaceutical Application of suspension:  Suspension is usually applicable for drug which is insoluble or poorly soluble. E.G. Prednisolone  Suspension to prevent degradation of drug or to improve stability of drug. E.G. Ox tetracycline suspension  To mask the taste of bitter of unpleasant drug. E.G. Chloramphenicol palmitate suspension  Suspension of drug can be formulated for topical application E.G. Calamine lotion.